reports
ContextLogic Completes Sale of Substantially All Operating Assets and ...
ContextLogic Completes Sale of Substantially All Operating Assets and Liabilities Associated with Wish to Qoo10 Transaction Enables Company to Preserve ~$2.7 Billion of Net Operating Losses (NOLs) Rishi Bajaj Appointed Chief Executive Officer; Four New Independent Directors Join Board of Directors SAN FRANCISCO, April 19, 2024 (GLOBE NEWSWIRE) -- ContextLogic Inc. (NASDAQ: WISH) (“ContextLogic” or the “Company”), today announced that it has completed its previously announced transaction with Qoo10 Pte. Ltd. (“Qoo10”). As disclosed, ContextLogic entered into an agreement to sell substant...
Voxtur Engages ICP Securities Inc. for Automated Market Making Service...
Voxtur Engages ICP Securities Inc. for Automated Market Making Services TORONTO and TAMPA, Fla., April 19, 2024 (GLOBE NEWSWIRE) -- (TSXV: VXTR; OTCQB: VXTRF), a North American technology company creating a more transparent and accessible real estate lending ecosystem, is pleased to announce that it has engaged the services of ICP Securities Inc. ("ICP") to provide automated market making services, including use of its proprietary algorithm, ICP Premium™, in compliance with the policies and guidelines of the TSX Venture Exchange and other applicable legislation. ICP will receive a fee of...
Oak Valley Bancorp Reports 1st Quarter Results
Oak Valley Bancorp Reports 1st Quarter Results OAKDALE, Calif., April 19, 2024 (GLOBE NEWSWIRE) -- Oak Valley Bancorp (NASDAQ: OVLY) (the “Company”), the bank holding company for Oak Valley Community Bank and their Eastern Sierra Community Bank division, recently reported unaudited consolidated financial results for the first quarter of 2024. For the three months ended March 31, 2024, consolidated net income was $5,727,000, or $0.69 per diluted share (EPS). This compared to consolidated net income of $5,865,000, or $0.71 EPS, for the prior quarter and $9,225,000, or $1.12 EPS, for the sam...
Millicom (Tigo) share repurchase activity
Millicom (Tigo) share repurchase activity Millicom (Tigo) share repurchase activity Luxembourg, April 19, 2024 – Pursuant to the share repurchase program announced on December 15, 2023, Millicom repurchased 38,891 of its Swedish Depository Receipts (SDRs) between April 15, 2024 and April 19, 2024, as detailed in the table below. Trade DateNumber of SDRs repurchasedDaily average price paid* (SEK) Daily repurchase amount* (SEK)04/15/20249,279218.21632,024,82904/16/20248,720216.21501,885,39504/17/20248,720215.31721,877,56604/18/20245,172218.05301,127,77004/19/20247,000217.83541,524,848 * E...
Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form...
Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing FLORHAM PARK, N.J., April 19, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: CELU) (the “Company”), a regenerative medicine company developing placental-derived allogeneic cell therapies and advanced biomaterial products, announced today that on April 17, 2024, the Company received notification from the Listing Qualifications department of the Nasdaq Stock Market LLC (“Nasdaq”) stating that because the Company has not yet filed its Annual Report on Form 10-K for the year ended December 31, 2023, it is no longer in comp...
Wrap Technologies Receives Nasdaq Notification of Non-Compliance with ...
Wrap Technologies Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1) MIAMI, April 19, 2024 (GLOBE NEWSWIRE) -- Wrap Technologies, Inc. (Nasdaq: WRAP) (“Wrap” or the “Company”), the makers of BolaWrap and the innovative public safety solutions platform powered by artificial intelligence (“AI”), virtual reality and data, today reports that it has received a letter from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not in compliance with the requirements of Nasdaq Listing Rule 5250(c)(1) as a result o...
IHT S-3 OPENS DOORS FOR DIVERSIFICATION CAPITAL INFUSION
IHT S-3 OPENS DOORS FOR DIVERSIFICATION CAPITAL INFUSION Phoenix, AZ, April 19, 2024 (GLOBE NEWSWIRE) -- InnSuites Hospitality Trust (NYSE American: IHT) IHT management announces Filing an S-3, allowing the potential to offer and sell up to 1,000,000 shares of IHT common stock, without par value (“Common Stock”), of the Company. The S-3 prospectus includes the details as it relates to shares of IHT Common Stock that may be offered and issued from time to time. The amount of gross proceeds received will depend upon the number of shares issued, and the market price of the Common Stock at...
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing...
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) SAN CARLOS, Calif., April 19, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) (“Iovance” or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer, today announced that on April 18, 2024 (the “Date of Grant”), the Company approved the grant of inducement stock options covering an aggregate of 79,310 shares of Iovance’s common stock to thirty-seven new, non-exec...
ASLAN Pharmaceuticals Announces Receipt of Nasdaq Notice
ASLAN Pharmaceuticals Announces Receipt of Nasdaq Notice SAN MATEO, Calif. and SINGAPORE, April 19, 2024 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq: ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced that it received a letter (the “Letter”) on April 18, 2024 from The Nasdaq Stock Market (“Nasdaq”) informing the Company that it failed to maintain the continued listing requirement under Nasdaq Listing Rule 5550(b)(1) for the Nasdaq Capital Market, which requires that a listed compa...
GFG Closes Private Placement Financing
GFG Closes Private Placement Financing NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRES SASKATOON, Saskatchewan, April 19, 2024 (GLOBE NEWSWIRE) -- GFG Resources Inc. (TSXV: GFG) (OTCQB: GFGSF) (“GFG” or the “Company”) has closed its private placement financing (the “Offering”) (see news release dated ) for gross proceeds of C$2,505,866. In connection with the Offering, Alamos Gold Inc. (“Alamos”) (TSX: AGI; NYSE: AGI) purchased securities to maintain their 9.9% interest in the Company. Pursuant to the Offering, GFG issued (i) 9,278,635 units of the Company (“Units”)...
North American Construction Group Ltd. First Quarter Results Conferenc...
North American Construction Group Ltd. First Quarter Results Conference Call and Webcast Notification ACHESON, Alberta, April 19, 2024 (GLOBE NEWSWIRE) -- North American Construction Group Ltd. (“NACG” or “the Company”) (TSX:NOA.TO/NYSE:NOA) announced today that it will release its financial results for the first quarter ended March 31, 2024 on Wednesday, May 1, 2024 after markets close. Following the release of its financial results, NACG will hold a conference call and webcast on Thursday, May 2, 2024, at 7:00 a.m. Mountain Time (9:00 a.m. Eastern Time). The call can be accessed by dia...
Notice of 2024 First Quarter Results Conference Call and Webcast for I...
Notice of 2024 First Quarter Results Conference Call and Webcast for Investors and Analysts and Annual Meeting of Shareholders First Quarter Conference Call and WebcastVirtual Annual Meeting Date:May 9, 2024Date:May 9, 2024 Time:1:00 PM (Eastern Time)Time:11:00 AM (Eastern Time) EDMUNDSTON, New Brunswick, April 19, 2024 (GLOBE NEWSWIRE) -- Acadian Timber Corp. will release its 2024 first quarter results after market close on Wednesday, May 8, 2024, which will be available on our website at under “Press Releases.” The release will be followed by a conference call and webcast o...
Comstock to Host 1Q24 Earnings Call on April 30, 2024
Comstock to Host 1Q24 Earnings Call on April 30, 2024 VIRGINIA CITY, Nev., April 19, 2024 (GLOBE NEWSWIRE) -- Comstock Inc. (NYSE: LODE) (“Comstock” or the “Company”) is pleased to announce that its Executive Chairman, Director & CEO, Corrado De Gasperis, and its COO, William McCarthy, will be presenting an overview of the Company’s 1Q24 financial results, upcoming milestones, and how the Comstock’s systemic platform is optimizing results on Tuesday, April 30, 2024, via a webinar. Investors and all other interested parties are invited to register below. Date: April 30, 2024Time: 8:00 am...
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(...
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) NOVATO, Calif., April 19, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultrarare diseases, today reported the grant of 44,965 restricted stock units of the company’s common stock to 14 newly hired non-executive officers of the company. The awards were approved by the compensation committee of the company’s board of directors and granted under the Ultragenyx Employment Inducement Plan...
Gulf Resources Announces Receipt of Nasdaq Non-Compliance Notice
Gulf Resources Announces Receipt of Nasdaq Non-Compliance Notice SHOUGUANG, China, April 19, 2024 (GLOBE NEWSWIRE) -- Gulf Resources, Inc. (NASDAQ: GURE) (“Gulf Resources” or the “Company”), a leading manufacturer of bromine, crude salt and specialty chemical products in China, today announced that it received a notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that due to the Company’s failure to timely file its Annual Report on Form 10-K for the fiscal year ended December 31, 2023 (the “2023 Form 10-K”), with...
Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delaye...
Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly Report CHASKA, Minn., April 19, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (the “Company”) announced today that, on April 15, 2024, the Company received a notification letter (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, as a result of the Company’s delay in filing its Quarterly Report on Form 10-Q for the fiscal quarter ended February 25, 2024 (the “Q3 Form 10-Q”) and its continued delay in filing its Quarterly Rep...
Arhaus Announces Showroom Opening in Greenwich, Connecticut
Arhaus Announces Showroom Opening in Greenwich, Connecticut The home brand unveils a 5,300 square-foot destination for heirloom quality furnishings BOSTON HEIGHTS, Ohio, April 19, 2024 (GLOBE NEWSWIRE) -- , a leader in artisan-crafted furniture and home décor, announces the opening of its new 5,300 square-foot showroom in Greenwich, Connecticut, located near the top of Greenwich Avenue in the city’s downtown shopping district. This marks the brand’s third showroom in Connecticut, with other locations in Farmington and Norwalk. The new Greenwich showroom is an inspiring destination ...
Hepion Pharmaceuticals Initiates Wind-Down Activities in Phase 2b ‘ASC...
Hepion Pharmaceuticals Initiates Wind-Down Activities in Phase 2b ‘ASCEND-NASH’ Trial EDISON, N.J., April 19, 2024 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company that has been developing a treatment for non-alcoholic steatohepatitis (“NASH”), hepatocellular carcinoma (“HCC”), and other chronic liver diseases, today announced that it has begun wind-down activities in its ASCEND-NASH Trial, while continuing to explore strategic alternatives, as previously announced in December 2023. ASCEND-NASH is a Phase 2b, randomized, multi-cen...
Vaxxinity Announces Intention to Voluntarily Delist and Deregister its...
Vaxxinity Announces Intention to Voluntarily Delist and Deregister its Class A Common Stock CAPE CANAVERAL, Fla., April 19, 2024 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (“Vaxxinity”, “we”, “us” or the “Company”) (Nasdaq: VAXX), a U.S. company pioneering the development of a new class of medicines, today announced its intention to voluntarily delist from the Nasdaq Global Market (“Nasdaq”) and to deregister its Class A common stock under Section 12(b) and Section 12(g) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and suspend its reporting obligations under Section 1...
Correction to Company announcement – No. 23 / 2024
Correction to Company announcement – No. 23 / 2024 Correction to Company announcement – No. 23 / 2024 Copenhagen, Denmark, April 19, 2024 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, has a correction to company announcement No. 23 /2024, April 19, 2024 - regarding transactions in Zealand’s shares or related securities conducted by persons discharging managerial responsibilities and/or their closely associated persons it was reported that mem...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.